Cancer Center– A Cancer Center Designated by
the National Cancer Institute

Clinical Trials in the Category "Lymphoma"

Drug Intervention Trials that are Recruiting

Study Title
 Principal Investigator Disease Category
A Phase 2 Open Label Trial of SGN-35 for Systemic Anaplastic Large Cell Lymphoma Michael Link
 Lymphoma
Lymphoma, Non-Hodgkin
Reduced Duration Standford V Chemotherapy With Low-Dose Tailored-Field Radiation For Favorable Risk Pediatric Hodgkin Lymphoma Michael Link
 Lymphoma
Donor Stem Cell Transplant in Treating Patients With Relapsed Follicular Non-Hodgkin Lymphoma After First Complete Remission Ginna Laport
 Lymphoma
Lymphoma, Non-Hodgkin
A Pivotal Open-Label Trial of SGN-35 for Hodgkin Lymphoma Sandra Jeane Horning
 Lymphoma, Hodgkin Disease
Hodgkin Disease
A Phase I Dose Escalation Study of Weekly SGN-35 Alone and in Combination With Gemcitabine in HL Sandra Jeane Horning
 Lymphoma, Hodgkin Disease
Hodgkin Disease
Blood Cancer
Therapy for Pediatric Hodgkin Lymphoma Michael Link
 Lymphoma, Hodgkin Disease
Hodgkin Disease
Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin's Disease Michael Link
 Lymphoma


Other Trials that are Recruiting

Study Title
 Principal Investigator Disease Category
NMDP Research Database for Allogeneic Unrelated Hematopoietic Stem Cell Transplantation David Miklos
 Lymphoma, Non-Hodgkin
Leukemia, Lymphocytic
Multiple Myeloma
Research Sample Repository for Allogeneic Unrelated Hematopoietic Stem Cell Transplantation Robert S Negrin
Judith Anne Shizuru
 Leukemia, Myeloid
Lymphoma, Non-Hodgkin
Multiple Myeloma
Bone Marrow Grafting for Leukemia and Lymphoma Robert S Negrin
David Miklos
 Leukemia
Lymphoma
Hematologic Diseases
Study of Late-Occurring Complications in Childhood Cancer Survivors Dr. Neyssa Marina
 Leukemia
Sarcoma
Retinoblastoma
Lymphoma
Retinal Neoplasms

Trials not Recruiting

Study Title
 Principal Investigator Disease Category
Rituximab in Treating Patients With Hodgkin's Lymphoma
(No longer recruiting) 		Sandra Jeane Horning
 Lymphoma
Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic Dendritic Cells
(Completed) 		Ronald Levy
 Multiple Myeloma
Allo BMT in Advanced Leukemia or High Grade Lymphoma
(No longer recruiting) 		Robert Lowsky
 Lymphoma, Non-Hodgkin
Enrichment & Purging of Stem Cells in Non-Hodgkin's Lymphoma
(No longer recruiting) 		Robert S Negrin
 Lymphoma, Non-Hodgkin
High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma
(No longer recruiting) 		Wen-Kai Weng
 Lymphoma, Non-Hodgkin
Combination Chemotherapy in Treating Children or Adolescents With Newly Diagnosed Stage III or Stage IV Lymphoblastic Lymphoma
(Completed) 		Dr. Neyssa Marina
 Lymphoma
Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation
(Completed) 		Dr. Neyssa Marina
 Lymphoma
Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients
(No longer recruiting) 		Gary V Dahl
 Leukemia
Lymphoma
Tumor Lysis Syndrome
Hyperuricemia
Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia
(No longer recruiting) 		Dr. Neyssa Marina
 Leukemia
Lymphoma
Neuroblastoma
Medulloblastoma
Bortezomib, Ifosfamide, and Vinorelbine in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy
(Suspended) 		Dr. Neyssa Marina
 Lymphoma


The physicians of the Stanford Cancer Center are engaged in more than 250 clinical trials.  Contracts with some of our clinical trial sponsors prevent us from listing specific trial information on our web site. Please contact the Stanford Cancer Clinical Trials Office at 650-498-7061 for information about additional open clinical trials.

Stanford Medicine Resources:

Footer Links: